viernes, 17 de marzo de 2017

[OFER-TRABEC] NAC: Researcher in Molecular Oncology

Boletín semanal de ofertas de empleo publico

Institución:Vall d'Hebron Research Institute
We are currently looking for highly motivated candidates to join the Group of Molecular Oncology of the Vall d'Hebron Research Institute. The candidate will continue an established research line focusing on the role of unconventional myosins in colorectal cancer. The project will involve the use of a variety of cell/molecular biology techniques including in vitro systems, animal models and large tumor collections.

Education and qualifications:
♣ Have a Bachelor of Science and a Master's Degree.
♣ Have a minimum of three years of work experience in a group of cancer research.
♣ Have at least two original publications in international journals.
♣ Be licensed to work with animals and have a minimum of three years of experience in this type of experiments.

Labour conditions:
♣ Gross annual salary: 15,600.00 €.
♣ Contract to cover sickness replacement.
♣ Immediate incorporation.
♣ Part time position: 28 hours per week.

Applicants should submit a full Curriculum Vitae and a cover letter with the reference Researcher to the following email addresses: and

Please state this reference: BFC2017

Información complementaria de la oferta:
Selected Publications

Cartón-García F, Overeem AW, Nieto R, Bazzocco S, Dopeso H, Macaya I, Bilic J, Landolfi S, Hernandez-Losa J, Schwartz S Jr, Ramon y Cajal S, van Ijzendoorn SC, Arango D. Myo5b knockout mice as a model of microvillus inclusion disease. 2015 Scientific Reports, Jul 23;5:12312. doi: 10.1038/srep12312. - (Impact Factor: 5.6)

Bazzocco S, Dopeso H, Carton-Garcia F, Macaya I, Andretta E, Chionh F, Rodrigues P, Garrido M, Alazzouzi H, Nieto R, Sanchez A, Schwartz S Jr, Bilic J, Mariadason JM, Arango D. Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. Clin Cancer Res. 2015 Aug 15;21(16):3695-704. doi: 10.1158/1078-0432.CCR-14-2457. Epub 2015 May 5. PMID: 25944804 - (Impact Factor: 8.7)

Rodrigues P, Macaya I, Bazzocco S, Mazzolini R, Andretta E, Dopeso H, Mateo-Lozano S, Bilić J, Cartón-García F, Nieto R, Suárez-López L, Afonso E, Landolfi S, Hernandez-Losa J, Kobayashi K, Cajal SR, Tabernero J, Tebbutt NC, Mariadason JM, Schwartz S Jr, Arango D. RHOA inactivation enhances Wnt signaling and promotes colorectal cancer. Nature Communications. 2014 Nov 21;5:5458. - (Impact Factor: 10.7)

Mazzolini R, Dopeso H, Mateo-Lozano S, Chang W, Rodrigues P, Bazzocco S, Alazzouzi H, Landolfi S, Hernández-Losa J, Andretta E, Alhopuro P, Espín E, Armengol M, Tabernero J, Ramón Y Cajal S, Kloor M, Gebert J, Mariadason JM, Schwartz S Jr, Aaltonen LA, Mooseker MS, Arango D. Brush border Myosin Ia has tumor suppressor activity in the intestine. Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1530-5. Epub 2012 Jan 18. - (Impact Factor: 9.8)

No hay comentarios:

Publicar un comentario